Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granulocyte-Colony Stimulating Factor Treatment for Acute Ischemic Stroke
IRCT201208081584N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2012
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of filgrastim in ischemic stroke (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Clinical response and Radiological response. Started Sep 2012; status: completed.
02
Drugs
filgrastim
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT201208081584N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201208081584N2.